0001078782-12-001644.txt : 20120615 0001078782-12-001644.hdr.sgml : 20120615 20120615161310 ACCESSION NUMBER: 0001078782-12-001644 CONFORMED SUBMISSION TYPE: 8-A12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20120615 DATE AS OF CHANGE: 20120615 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMA INVESTING NEWS, INC. CENTRAL INDEX KEY: 0001520047 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 320337695 STATE OF INCORPORATION: NV FISCAL YEAR END: 0228 FILING VALUES: FORM TYPE: 8-A12G SEC ACT: 1934 Act SEC FILE NUMBER: 000-54738 FILM NUMBER: 12910319 BUSINESS ADDRESS: STREET 1: 1810 EAST SAHARA AVE STREET 2: SUITE 1571 CITY: LAS VEGAS STATE: NV ZIP: 89104 BUSINESS PHONE: 702-664-6555 MAIL ADDRESS: STREET 1: 1810 EAST SAHARA AVE STREET 2: SUITE 1571 CITY: LAS VEGAS STATE: NV ZIP: 89104 8-A12G 1 form8a_8a12g.htm FORM 8-A Form 8-A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-A


FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR (g) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

PHARMA INVESTING NEWS, INC.

 (Exact name of registrant as specified in its charter)

 

Nevada

  

 333-174271

  

32-0337695

(State or other jurisdiction

  

(Commission File Number)

  

(IRS Employer

of Incorporation)

  

  

  

Identification Number)

  

  

  

  

  

  

  

1810 East Sahara Ave

Suite 1571

Las Vegas, NV 89104

 (Address of principal executive offices)

 

(702) 664-6555      

(Registrant’s telephone number)

  

  

  

  

 

  

  


Securities to be registered pursuant to Section 12(b) of the Act:  None


If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box.       .


If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box.   X . 


Securities Act registration statement file number to which this form relates: 333-174271


Securities to be registered pursuant to Section 12(g) of the Act:



Title of each class

to be so registered


___________________________________________________


Common Shares, par value $0.001 per share













INFORMATION REQUIRED IN REGISTRATION STATEMENT


Item 1.  Description of Registrant’s Securities to be Registered


Pharma Investing News, Inc. (the “Registrant”) hereby incorporates by reference the description of its common stock to be registered hereunder in the section captioned “Description of Securities” in the Registrant’s Registration Statement on Form S-1/A (File No. 333-174271), as amended and filed with the U.S. Securities and Exchange Commission (the “Commission”) on August 30, 2011 (the “Registration Statement”).


Item 2.  Exhibits


The following exhibits are incorporated herein by reference:


Exhibit     

Description

Reference

         

3.01     

Articles of Incorporation

Filed with the SEC on May 17, 2011 as part of our Registration Statement on Form S-1.

3.02

ByLaws

Filed with the SEC on May 17, 2011 as part of our Registration Statement on Form S-1.




SIGNATURE


Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.



PHARMA INVESTING NEWS, INC.


            

Date:  June 15, 2012

By: /s/ Robert Lawrence       

      

Name: Robert Lawrence

    

Title: President and Chief Executive Officer